Charles Schwab’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-312,756
| Closed | -$36K | – | 3215 |
|
|
2018
Q4 | $36K | Sell |
312,756
-936,991
| -75% | -$615K | ﹤0.01% | 3138 |
|
|
2018
Q3 | $2.13M | Sell |
1,249,747
-62,283
| -5% | -$111K | ﹤0.01% | 2411 |
|
|
2018
Q2 | $2.28M | Buy |
1,312,030
+88,386
| +7% | +$153K | ﹤0.01% | 2336 |
|
|
2018
Q1 | $2.24M | Buy |
1,223,644
+172,236
| +16% | +$364K | ﹤0.01% | 2290 |
|
|
2017
Q4 | $2.35M | Buy |
1,051,408
+106,222
| +11% | +$264K | ﹤0.01% | 2251 |
|
|
2017
Q3 | $2.74M | Sell |
945,186
-35,368
| -4% | -$121K | ﹤0.01% | 2160 |
|
|
2017
Q2 | $4.36M | Buy |
980,554
+119,492
| +14% | +$493K | ﹤0.01% | 1889 |
|
|
2017
Q1 | $4.01M | Buy |
861,062
+82,163
| +11% | +$476K | ﹤0.01% | 1885 |
|
|
2016
Q4 | $4.74M | Buy |
778,899
+37,560
| +5% | +$196K | 0.01% | 1770 |
|
|
2016
Q3 | $4.08M | Buy |
741,339
+69,354
| +10% | +$325K | ﹤0.01% | 1776 |
|
|
2016
Q2 | $2.55M | Buy |
671,985
+321,611
| +92% | +$1.09M | ﹤0.01% | 1943 |
|
|
2016
Q1 | $968K | Buy |
350,374
+8,142
| +2% | +$29.5K | ﹤0.01% | 2361 |
|
|
2015
Q4 | $1.94M | Buy |
342,232
+33,129
| +11% | +$202K | ﹤0.01% | 2096 |
|
|
2015
Q3 | $1.64M | Sell |
309,103
-10,714
| -3% | -$82.9K | ﹤0.01% | 2180 |
|
|
2015
Q2 | $2.65M | Buy |
319,817
+10,426
| +3% | +$50.5K | ﹤0.01% | 1934 |
|
|
2015
Q1 | $1.43M | Buy |
309,391
+79,772
| +35% | +$259K | ﹤0.01% | 2236 |
|
|
2014
Q4 | $701K | Buy |
229,619
+34,770
| +18% | +$103K | ﹤0.01% | 2498 |
|
|
2014
Q3 | $543K | Buy |
194,849
+3,351
| +2% | +$12.2K | ﹤0.01% | 2557 |
|
|
2014
Q2 | $780K | Buy |
191,498
+13
| +0% | +$55 | ﹤0.01% | 2439 |
|
|
2014
Q1 | $1.02M | Buy |
191,485
+3,282
| +2% | +$18.4K | ﹤0.01% | 2279 |
|
|
2013
Q4 | $1.04M | Buy |
188,203
+25,138
| +15% | +$108K | ﹤0.01% | 2246 |
|
|
2013
Q3 | $742K | Buy |
163,065
+1
| +0% | +$4 | ﹤0.01% | 2364 |
|
|
2013
Q2 | $698K | Buy |
+163,064
| New | +$819K | ﹤0.01% | 2354 |
|
Other funds holding SGYP
Charles Schwab's SGYP Position: Q1 2019 in Review
Charles Schwab sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q1 2019, closing a stake of 312,756 shares — an estimated $36K sold.
Charles Schwab first reported a position in SGYP in Q2 2013 and held it in 23 quarters. The position peaked at $4.74M in Q4 2016. 12 funds tracked by Wall St. Rank hold SGYP as of Q1 2019.
- Charles Schwab reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q1 2019 after selling out during the quarter.
- Charles Schwab sold 312,756 Synergy Pharmaceuticals, Inc Common Stock shares in Q1 2019, an estimated $36K.
- Charles Schwab first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2013 and held it in 23 quarters.
- Charles Schwab's Synergy Pharmaceuticals, Inc Common Stock position peaked at $4.74M in Q4 2016.
- 12 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q1 2019.
Based on Charles Schwab's 13F filing for Q1 2019, filed 14 May 2019.